B
cells that produce disease-associated autoantibodies are subject to stringent negative selection, namely, deletion, functional silencing (anergy), and conversion of self-reactive receptors to non-self-reactive receptors (receptor editing) (1-7). However, it remains a paradox that Abs reactive with selfconstituents are found in sera of healthy individuals. In the 1980s, several groups reported that a substantial proportion of serum Abs in healthy humans and rodents as well as in lower phylogenetic species were autoreactive and polyreactive (8 -15) . These Abs are thought to arise naturally without Ag stimulation because they are present in cord blood (16) and in newborn humans (17) and mice (18) , as well as in mice housed in germfree conditions and fed an Ag-free diet (19) . They are therefore referred to as natural autoantibodies (NAAs). 3 NAAs are mainly of the IgM class and are encoded by germline V H and V L genes (13, 20, 21) . Studies over the past 20 -30 years have demonstrated that NAAs provide critical early protection against pathogens (22) (23) (24) (25) , and they may also play a role in self-tolerance by facilitating clearance of apoptotic cells and other self-Ags (26) . However, it is not clear whether B cells producing NAAs can actively participate in foreign Ag-induced immune responses, in particular, a T cell-dependent (TD) memory response, and, if so, whether the inherent polyreactivity and autoreactivity of such Abs constitute a threat to the host.
We recently generated site-directed transgenic (sd-tg) mice in which the H chain gene of a prototypic NAA is inserted into the IgH locus (27) . This NAA, named ppc1-5, is encoded by the V H 7183.14 and V1 germline genes and was derived from the liver of a neonatal mouse. It binds DNA, actin, phosphocholine (PC), as well as a variety of self-Ags and foreign Ags (20) . Despite their autoreactivity, B cells expressing ppc1-5H/1 NAA are not eliminated in the ppc-1-5H sd-tg mice, but instead they are positively selected during their primary development (27) . In this regard, they are similar to B-1 B cells (28) . However, the ppc1-5 B cells are located predominantly in the follicles of the spleen and lymph nodes, are also circulating through the peripheral blood, and exhibit a phenotype (IgM int IgD low CD23 high CD5 Ϫ ) that is different from typical B-1 or follicular B cells (27) . It is not clear whether they represent a subtype of CD5 Ϫ B-1 B cells or Ag-experienced follicular B cells. Regardless of their cellular origin, the ppc1-5 NAA B cells do not appear to be "anergic" in terms of response to BCR cross-linking and LPS stimulation (27) .
In this study, we investigate the immune response of ppc1-5H sd-tg mice to the TD Ag PC conjugated to keyhole limpet hemocyanin (KLH). The ppc1-5H mice represent a particularly useful model to examine TD-immune responses of NAA B cells because the transgene is inserted in the IgH locus and can undergo somatic hypermutation (SHM) and class switch recombination (CSR), both of which are defining features of the TD response. We show that the ppc1-5H/1 NAA B cells can participate in an early anti-PC IgM Ab response, but they neither sustain this response nor do they mount a significant memory IgG response. Immunohistologic examination of the spleen revealed many IgM a -1 Ab-forming cells (AFCs) but few, if any, IgG1 a -1 AFCs. Moreover, efforts to isolate IgG ppc1-5H/1 B cells from memory response by hybridoma generation and cDNA cloning have demonstrated the extreme paucity of such B cells. Instead, most of the recovered IgG-1 B cell clones had replaced the ppc1-5 V H with an endogenous V H . Taken together, we conclude that the ppc1-5H/1 NAA B cells are excluded from the memory IgG Ab repertoire during a TD-immune response and that a molecular mechanism for eliminating NAA BCR is V H replacement.
Materials and Methods

Mice
The ppc1-5 H-chain sd-tg mice have been described previously (27) . The ppc1-5 VDJ H is joined to the constant region of the 129/Sv mouse strain and therefore the transgene-encoded BCR is of the IgH a allotype. The C57BL/6 (referred to as B6) mice were purchased from The Jackson Laboratory. All mice were housed under specific pathogen-free conditions. In this study, heterozygous ppc1-5H sd-tg mice were used for all of the experiments.
Ag and immunization
PC-KLH was prepared as described previously (29) and was a gift from Dr. M. Rittenberg (Oregon Health & Science University, Portland, OR). It had a hapten:protein ratio of 80 haptens per 100,000 Da of KLH. The ppc1-5H sd-tg mice and their tg-negative littermates (8 -11 wk old) were immunized i.p. with 200 g of PC-KLH in CFA, followed by 50 g of PC-KLH in CFA or IFA at day 28, and boosted with 20 g of PC-KLH in saline at day 134 after the first immunization. Serum and tissue samples were obtained at various time points after immunization. Mice receiving PC-KLH in CFA during secondary immunization had slightly better serum anti-PC Ab responses than mice receiving IFA. Therefore, the data presented in this study are from CFA twice-injected mice.
Hybridoma generation
Three days after PC-KLH boost, mice were sacrificed and spleen cells were isolated and fused with SP2/0 myeloma cells without in vitro stimulation using the established procedure (7) . Monoclonal hybridomas that produced Ab were saved for further analysis.
ELISA
Binding to Ags was conducted as described previously (20) . Briefly, plates were coated with 2 g/ml PC-histone, PC-KLH, or 5 g/ml ssDNA and incubated with sera or hybridoma supernatants. Binding was detected with alkaline phosphatase (AP)-conjugated anti-or anti-(Southern Biotechnology Associates) or with biotinylated anti-IgM a , anti-IgG1 a , anti-IgM b , or anti-IgG1 b (BD Biosciences) followed by AP-avidin. For measurement of serum IgM a -and IgG1 a -Abs, plates were coated with anti-IgM a or IgG1 a (BD Biosciences) and Abs were detected by AP-conjugated anti-. Determination of Ig isotype and concentration of hybridoma supernatants was as described previously (20) . Plates were coated with 2 g/ml goat anti-mouse or , incubated with cell culture supernatants, and developed with AP-labeled anti-IgM, anti-IgG1, anti-IgG2a, anti-IgG2b, or anti-IgG3 (Southern Biotechnology Associates).
Immunohistochemistry
Mouse spleens were embedded in OCT and flash frozen in liquid nitrogen. Five-micrometer sections of frozen tissue were fixed in 2% paraformaldehyde, quenched in 0.3% H 2 O 2 , and blocked with 1% BSA. Double stains were conducted with anti-1-biotin along with anti-GL7-FITC, anti-IgG1 a -FITC, or anti-IgM a -FITC (BD Biosciences) for 60 min followed by incubation with AP-labeled anti-FITC (Sigma-Aldrich) and the avidin-biotin complex (Vectastain Elite Kit; Vector Laboratories) for 30 min. AP and HRT were developed with Fast Blue (Sigma-Aldrich) and diaminobenzidine (DakoCytomation), respectively.
Ig H chain RT-PCR
Total RNA from sorted 1 ϩ splenic cells (ϳ10 7 ) was extracted using the RNeasy Mini Kit (Qiagen) and dissolved in 20 l of water. Reverse transcription was conducted using 2 l of total RNA and a Superscript II cDNA synthesis kit (Invitrogen) according to the manufacturer's instructions. The following primers were used for cDNA synthesis: IgG1/2B (5Ј-GGACAGGGATCCAGATTCC-3Ј) and IgG3B (5Ј-GGACAGGGCTCC ATAGTTCC-3Ј). PCR amplification of cDNA was conducted using V H 7183 primer (5Ј-GGAGTCTGG(AϩG)GGAGGCTT-3Ј) and downstream IgG constant region primers IgG1/2A (5Ј-GGGCCAGTGGATAG AC(AϩCϩT)GATGG-3Ј) and IgG3A (5Ј-GGACCAAGGGATAGACAG ATGG-3Ј), respectively. PCR conditions include an initial denaturation at 92 o C for 9 min followed by 40 
Cloning and sequencing
PCR products were analyzed on 1% agarose gels and DNA amplicons of interest were excised from the gel and purified using a QIAquick gel extraction kit (Qiagen). PCR fragments were cloned directly into the PCR4-TOPO vector (Invitrogen) and then transformed into Escherichia coli DH5␣-T1 R . Individual colonies were cultured and plasmid DNA was extracted using the QIAprep kit (Qiagen). Sequencing reactions were conducted on an Applied Biosystems PRISM 3130xl Genetic Analyzer. Each clone was sequenced in both directions using M13 forward and T3 reverse primers. V H sequences analyzed using Finch TV (Geospiza) software were aligned and compared with germline sequences found at the National Center for Biotechnology Information (NCBI) database (http://www.ncbi.nlm. nih.gov/igblast/) using a ClustalW 1.8 DNA algorithm.
MACS purification of splenic B cells
To obtain enriched populations of GL-7 ϩ and GL-7 Ϫ cells, splenic cells from the immunized ppc1-5H sd-tg mice were depleted of CD3 ϩ cells by MACS using anti-CD3 microbeads (Miltenyi Biotec) per the manufacturer's instructions. The negative fraction was incubated with anti-GL7-biotin (BD Biosciences) followed by avidin microbeads and separated by MACS column. Flow cytometric analysis showed that the GL7 ϩ cells were enriched by 40 -60% and GL7
Ϫ cells were Ͼ98% pure.
Ligation-mediated PCR (LM-PCR)
High molecular mass genomic DNA was isolated from the bone marrow, total spleen, and splenic GL7 ϩ and GL7 Ϫ cells as described previously (30) . LM-PCR was performed according to a previously published method (31) . Briefly, the BW linker (20 pM) was ligated to genomic DNA (2 g) in a volume of 20 l with 5 U of T4 DNA Ligase (Invitrogen) at 16 o C for 12-14 h. After ligation, the DNA was denatured at 95°C for 5 min and subjected to a seminested PCR. For the first-round PCR, 30 -40 ng of linker-ligated DNA was used as template and for the second-round PCR, 2 l of the primary PCR product was used. The conditions for primary and secondary PCR were 94 o C for 30 s, 63 o C for 45 s, 72 o C for 45 s, for 25 cycles, followed by an extension at 72 o C for 10 min. The 3Ј primer for both PCR was BW-1H, which recognizes the BW linker and the first three nucleotides of the heptamer (31) . The 5Ј primers were specific for the ppc1-5 V H leader intron sequence (5Ј-GTTGTATGCACATGAGACA GAGA-3Ј) and the framework 1 sequence (5Ј-GGAGTCTGGRGGAG GCTT-3Ј). The PCR for ␣-actin (32) was included as a control for DNA input.
Southern blotting
PCR products were run on 1% agarose gel and transferred to nylon membrane (Invitrogen) using an XCell II Blot Module (Invitrogen) according to the manufacturer's instructions. Membranes were hybridized with a biotinylated oligonucleotide probe (ppc1-5H CDR2 probe: 5Ј-TAGTTACAC CTACTATCCAGACAGTGTGAAGGGCC-3Ј) at 60 o C overnight using hybridization solution from DakoCytomation, followed by a stringent wash with 2ϫ SSC. A Phototope chemiluminescent detection kit with SDP-Star substrate (New England Biolabs) was used for signal detection. Finally, membranes were exposed to Thermo Fisher Scientific CL-XPosure Film.
RAG1 and RAG2 RT-PCR
Total RNA was extracted from bone marrow and splenic cells as described above. Reverse transcription was conducted using 0.3 g of total RNA and a Superscript II cDNA synthesis kit (Invitrogen) in 20 l of reaction mix. We used 2 l of cDNA for subsequent PCR amplification. The primers and conditions for RAG1 and RAG2 RT-PCR were as previously published (33) . ␤-Actin RT-PCR (32) was used as a control for RNA input.
Results
Ab responses in ppc1-5H sd-tg mice immunized with PC-KLH
We have shown previously (27) that in the heterozygous H chainonly ppc1-5H sd-tg mice, ϳ95% of the mature B cells express the ppc1-5H tg, of which ϳ30% express and the remaining express L chains. The ppc1-5H/1 B cells represent NAA-producing B cells while the majority of the -expressing B cells and the non-tg B cells are non-NAAs (27) . To determine whether NAA B cells can participate in TD-immune responses, we chose to immunize mice with a well-studied TD Ag, PC-KLH, because the ppc1-5 NAA binds p-nitrophenyl PC, the precursor of diazo-linked PCprotein conjugates (20) . Use of PC-KLH therefore guarantees engagement of the ppc1-5H/1 BCR by the Ag. Groups of heterozygous ppc1-5H sd-tg and non-tg B6 mice were immunized with PC-KLH three times over a period of 4 and half months. The mice were bled at various time points and the serum anti-PC Ab levels were measured using allotype-specific reagents because the tg-encoded Abs are of the IgH a allotype, whereas the non-tg-encoded Abs from B6 mice are IgH b . Increased levels of anti-PC IgM Abs were readily detected after initial immunization in both tg and non-tg mice, although the latter achieved a higher concentration (Fig. 1A) . However, different kinetics were observed between tg and non-tg IgM Abs during the course of primary and secondary responses: the tg-encoded IgM a Abs peaked at day 7 and decreased rapidly afterward, whereas the non-tg Abs reached a peak titer at day 14 and remained at high levels until at least day 28, when the mice received the second immunization. The tg IgM a Abs rose again after each subsequent immunization, whereas the non-tg IgM Abs did not further increase following secondary immunization, likely due to their high titers at that point. These results indicate that the ppc1-5 B cells were able to give rise to an early IgM Ab response upon Ag stimulation, but the response disappeared quickly. In contrast, the non-tg B cells had a slower but more sustainable IgM response.
As expected, the IgG response lagged behind the IgM response (Fig. 1A) . In non-tg mice, the anti-PC IgG1 Abs did not appear until day 28 and reached their peak shortly after the secondary immunization and remained at high levels until day 134. In tg mice, however, the anti-PC IgG1 a Abs only became detectable after secondary immunization and slowly rose to reach high levels at day 134, mainly due to an increase in the IgG Abs (see below).
Since the L chain is not predetermined in the ppc1-5H sd-tg mice, both and L chains can contribute to the IgH a Abs. To estimate the relative contribution of Abs to the anti-PC response, we measured the kinetics of IgH a -Abs. (We could not measure IgH a -because the anti-allotypic reagents are themselves mouse IgG/ and would cause high background with a secondary antimouse Ab.) The IgM a -Abs increased quickly and significantly (ϳ6-fold) after each immunization (Fig. 1B) , a response similar to that of the anti-PC IgM a Abs. In contrast, the IgG1 a -Abs only increased slightly (Ͻ2-fold) during the entire course of the immune response. These results suggest that the ppc1-5H/1 NAA B cells did not contribute significantly to the IgG Ab response and that the majority of the IgG Abs in the late phase of the response were of the non-NAA Abs.
To visualize the formation of AFCs, splenic sections from ppc1-5H sd-tg mice were stained with 1 in combination with IgM a or IgG1 a . Seven days after the primary immunization, clusters of darkly stained IgM a -1 AFCs were seen in the T zone/red pulp bridge channels ( Fig. 2A) . IgG1 a AFCs were rare in the primary response (data not shown), but they were frequent in the memory response. However, few IgG1 a cells coexpressed 1, consistent with the serum data.
Germinal center reaction in immunized ppc1-5H mice
To determine whether ppc1-5H/1 B cells can participate in germinal center (GC) reactions, consecutive spleen sections from the immunized mice were stained with anti-GL7-1, and IgM a -1. GCs were seen 9 -12 days after each immunization and were most numerous during memory responses. B cells expressing IgM a and 1 were readily identified in the GL7 ϩ GCs (Fig. 2B) . Consistent with the immunohistochemical results, flow cytometric analysis of the splenic cells from the immunized ppc1-5H mice showed a small but significant population of IgM a -1 B cells expressing a high level of GL-7 (Fig. 2C) . These results indicate that the ppc1-5H/1 NAA B cells can enter GCs.
Analysis of hybridomas from the immunized ppc1-5H mice
To further characterize B cells in the ppc1-5H sd-tg mice during memory anti-PC-KLH response, hybridomas were generated from the spleen of ppc1-5H mice 3 days after the third PC-KLH immunization. Three hundred hybridomas were analyzed: 242 (81%) were IgM and 58 (19%) were IgG (Fig. 3) . More than 30% (75 of 242) of the IgM hybridomas expressed 1. In contrast, Ͻ10% (5 of 58) of the IgG hybridomas were 1. To determine whether the 1 hybridomas represent ppc1-5H/1 NAA B cells, the presence of ppc1-5H sd-tg was analyzed by PCR. Thirty-nine (74%) of 53 IgM-1 hybridomas analyzed retained the ppc1-5H tg, but none of the five IgG-1 hybridomas did. Sequence analysis of some of the ppc1-5H/1 IgM hybridomas revealed few or no mutations in the V H and V genes (data not shown), indicating that they represent newly activated naive B cells rather than post-GC memory B cells. These IgM ppc1-5/1 hybridomas showed an Ag-binding pattern similar to that of the original ppc1-5 mAb, including binding to PC-KLH and DNA (data not shown) (27) .
The lack of ppc1-5H/1 IgG B cells in the memory response could be due to competition with B cells. We therefore crossed the ppc1-5H sd-tg to J del mice, which do not express the L chain. The mature B cell repertoire of the ppc1-5H/J del mice comprised Ͼ95% of tg ϩ / B cells and Ͻ5% of non-tg/ B cells (data not shown). Hybridomas were generated from two ppc1-5H/J del mice after PC-KLH immunization. A total of 209 hybridoma clones was screened by ELISA: 180 (86%) were IgM and 29 (14%) were IgG. Nineteen stable IgG hybridomas were established for further analysis. To our surprise, only two of the 19 hybridomas retained the ppc1-5H sd-tg and both of these were inactivated by nucleotide deletion (see below). All 19 hybridomas expressed a functional endogenous H chain (Table I) . Somatic mutations were identified in all 21 V H sequences and 18 of the 19 V sequences, indicating that these were GC-derived B cells.
A variety of endogenous V H genes were used by these hybridomas, including members from the Q52, J558, 7183, and VGam families. Interestingly, such diverse V H gene usage has also been observed in the memory anti-PC-KLH response in non-tg mice (34 -36), although the individual V H genes used are different. It appears that diversification of the Ab repertoire during memory anti-PC-KLH response is a feature common to both ppc1-5H and non-tg mice. FIGURE 2. AFC formation and GC reaction in ppc1-5H sd-tg mice. A, EF AFC formation in ppc1-5H mice during primary (7 days after the first immunization) and memory (9 days after the third immunization) responses to PC-KLH. Splenic sections were stained with anti-1 (brown) along with anti-IgM a or IgG1 a (blue). B, Immunohistochemical analysis of GC reaction in ppc1-5H sd-tg mice during memory response (9 days after the third immunization). Consecutive splenic sections were stained with anti 1-GL7 or anti 1-IgM a Abs. Many 1 ϩ IgM aϩ B cells are present in GL7 ϩ GCs. The lack of staining in the GC dark zone is likely due to the down-regulation of surface Ig on centrablasts. These are representative sections of three to five mice of each group. Original magnifications, ϫ100 and ϫ400. C, Flow cytometric analysis of 1-IgM a B cells isolated from the ppc1-5 sd-tg mice before and after PC-KLH immunization (8 days after secondary immunization). Levels of GL7 expression are shown as a histogram. At least five mice from each group were examined; plots shown are representative.
FIGURE 3.
Analysis of hybridomas derived from the ppc1-5H sd-tg mice following PC-KLH immunization. Hybridomas were generated from splenic B cells of five ppc1-5H sd-tg mice 3 days after PC-KLH memory challenge (see Materials and Methods for details). Ig isotypes were determined by ELISA. The presence or absence of the ppc1-5H sd-tg was determined by PCR and/or sequencing.
We compared the relative binding avidity of the IgG-1 hybridomas to that of an unmutated ppc1-5H/1 IgG Ab (from a transfectoma). Only 1 of the 19 hybdridomas had increased binding for PC-histone but 7 had improved binding for PC-KLH, indicating a selection toward the carrier protein, a phenomenon described previously in the memory anti-PC-KLH response in non-tg mice (37) . Notably, all 19 hybridomas had much reduced or undetectable binding for ssDNA.
Two hybridomas (F2-6 and F2-12) are of particular interest. They kept the ppc1-5H sd-tg yet expressed an endogenous IgH, V H Q52.2.4. The sd-tg in both hybridomas was inactivated by an eight-nucleotide deletion in the CDR2 resulting in stop codons (Fig. 4) . These two hybridomas were clonally related because they had the same eight-nucleotide deletion, expressed the same endogenous VDJ, and shared most, but not all, mutations in V H and V. Remarkably, the defunct ppc1-5 V H in both hybridomas (38) . The V gene is also unusual in these two hybridomas: it involves rearrangement of V2 to J1-C1. Such a combination is rare: of 44 V2 sequences we have identified in the NCBI Ig Blast Database, only 2 are joined to J1 and the remaining 42 are joined to J2. This is probably due to the fact that the V2 gene is further away from the J1-C1 cassette on the mouse locus. This unusual combination could be the result of receptor editing at the allele (30) . The observation of fewer mutations in V2 than in V H ppc1--5 in these two hybridomas is consistent with this prediction. Aside from the two hybridomas that inactivated the ppc1-5H tg by nucleotide deletion, the rest of the IgG-hybridomas lost the tg entirely either by deletion of the tg locus (7) or by V H replacement. The latter is a process by which the targeted V H gene is replaced by an upstream V H via secondary recombination mediated by a heptamer embedded at the 3Ј end of most of the V H genes (39). By examining the V H sequences, we found five clones, three hybridomas (F2-1, F2-2, and F2-9) and two cDNA clones (BG3-3 and CG1-2) (see below) that showed evidence of V H replacement (Fig.  5A) . These clones retained the unique ppc1-5 VDJ H junction sequence (or footprint) as part of the new V H CDR3 region. Four of the five clones appeared to have an initial D H to VDJ ppc1-5 rearrangement followed by a V H to D H -VDJ ppc1-5 recombination (Fig. 5B ) similar to what we described previously (39) . One clone (F2-2) did not contain an identifiable D H sequence and therefore could have resulted from direct V H to VDJ ppc1-5 recombination. Two clones (F2-1 and F2-2) had multiple non-templated (N) nucleotide additions at the new VD and/or DJ junctions, and therefore they must have undergone V H replacement in the bone marrow at the pro-B stage because the enzyme (TdT) responsible for N addition is thought to be active mainly in the pro-B cells (32, 40) . Clones F2-9 and CG1-2 had no apparent N additions except for P (palindromic) nucleotide addition, which does not require TdT (41) . These clones could have undergone V H replacement at a later stage of B cell development.
To formally prove that V H replacement has occurred at the ppc1-5H sd-tg site and to test whether V H replacement can take place in the bone marrow and spleen, we performed a linker-mediated PCR (LM-PCR) assay, which detects dsDNA breaks at the signal ends generated during Ig gene rearrangement (31) . Specific primers were designed to identify the signal breaks at the ppc1-5 V H replacement site (Fig. 5B) . A 300-bp DNA amplicon, corresponding to the ppc1-5 V H replacement product, was identified in the bone marrow samples from the ppc1-5H sd-tg mice (Fig. 5C ). The tail DNA from ppc1-5H mice and the bone marrow and splenic DNA from non-tg mice were used as negative controls and they did not show amplification products, demonstrating that the assay is specific for the ppc1-5 V H signal breaks. The splenic B cells from the immunized ppc1-5H mice (12 days after secondary immunization) also gave rise to a weak but distinct PCR amplicon. We then enriched the splenic B cells from the immunized ppc1-5H mice for GL-7 ϩ cells and found abundant signal breaks in the GL-7 ϩ B cell population (Fig. 5C ). Since V H replacement is thought to be a RAG-dependent process (42), we sought to confirm RAG expression by RT-PCR. As shown in Fig. 5D , RAG1 and RAG2 transcripts were detected in the bone marrow and spleen of the immunized ppc1-5H mice. Together, these results indicate that the ppc1-5 NAA B cells can undergo V H replacement at the sd-tg IgH allele in the bone marrow. The detection of dsDNA breaks and RAG activity in the spleen of the immunized mice suggests that V H replacement could also take place in the peripheral lymphoid tissue during an immune response. However, it is not clear whether the splenic B cells that are undergoing V H replacement represent immature B cells or mature GC B cells (see Discussion).
Analysis of IgH cDNA clones from the immunized ppc1-5H mice
To characterize the rare IgG ppc1-5H/1 B cells, we used another strategy to retrieve the V H genes directly from IgG 1 B cells. CD19 ϩ 1 ϩ splenic B cells were sorted from the ppc1-5H mice 3 days after the memory PC-KLH boost and RNA was extracted from the sorted cells, from which IgG cDNA clones were established using primers specific for C␥ and the 7183 V H family to which the ppc1-5 V H gene belongs. Of 110 nonidentical IgG V H cDNA clones from 1 ϩ B cells, 21 (19%) were ppc1-5H. Given that the 7183 primer can amplify V H genes from the 7183, S107, 3609N, and J606 families and that these families represent ϳ17% of the total V H repertoire (43), the ppc1-5 V H is therefore expressed by ϳ3% of the 1 IgG B cells and Ͻ1% of the total IgG B cells. This explains why such B cells were not recovered as hybridomas. Analysis of somatic mutation patterns in ppc1-5H ϩ and ppc1-5H Ϫ (endogenous) V H clones revealed that ϳ50% of the ppc1-5 V H sequences were germline, suggesting that they may represent pre-GC B cells. The remaining ppc1-5H sequences contained 1-6 mutations with an average mutational frequency of 2.9 per V H . The ratio of replacement:silent mutations for ppc1-5 CDRs was 3.5:1 and was 4.3:1 for framework regions (FWRs), both of which were similar to the ratios expected for random mutation (4.2:1 for ppc1-5 CDRs and 3.2:1 for FWRs). On the other hand, 83% of the endogenous V H had mutations and the mutational frequencies were relatively high (ranging from 1 to 24 and averaging 5.7 per V H ). The endogenous V H had a higher replacement:silent ratio in CDRs (4.8:1) than in FWRs (1.6:1), suggesting Ag selection. Collectively, our data from hybridoma and V H cDNA clone analyses demonstrate that B cells expressing IgG ppc1-5H/1 BCR were extremely rare in the memory anti-PC-KLH response and that the few surviving ones had relatively few mutations and did not show evidence of Ag selection.
Discussion
Upon TD Ag immunization, Ag-specific B cells follow one of two pathways: they either migrate to the extrafollicular (EF) region and become short-lived plasma cells or enter GC and develop into memory B cells or long-lived plasma cells (44) . During GC development, the Ab genes characteristically undergo switch recombination and SHM, leading to affinity maturation (45) (46) (47) (48) . The EF plasma cells give rise to the early Ab response, whereas the GCderived plasma cells sustain the Ab levels in the later phase of the immune response. Our findings of the rapid increase in serum anti-PC IgM a -1 Ab levels and the early appearance of IgM a -1 AFCs in the EF region of the spleen after PC-KLH immunization indicate that the ppc1-5H/1 NAA B cells can enter the EF pathway and differentiate to short-lived plasma cells upon Ag encounter. This demonstrates for the first time that a typical polyreactive and autoreactive NAA B cell can participate in the early phase of a TD-immune response and reinforces the importance of NAAs not only as a first line of natural defense but also as a bridge between innate and adaptive immunity.
The ppc1-5 NAA B cells can also enter GCs, but they rarely differentiate to IgG-producing cells in the late primary or memory responses as shown by serum Ab studies, immunohistochemical staining, and extensive hybridoma and V H clone analyses. This indicates a blockade or a counterselection of the NAA B cells in GC development. In contrast, the non-NAA B cells ( ϩ or tg Ϫ B cells) in ppc1-5H sd-tg mice are able to differentiate to IgG-producing cells and dominate the memory response. Fig. 6 summarizes the proposed developmental pathways of NAA and non-NAA B cells in ppc1-5H sd-tg mice following PC-KLH immunization.
The NAA B cells, although they do not directly participate in the memory response, can serve as precursors of the memory IgG non-NAA B cells via receptor editing. This is particularly evident in the ppc1-5H/J del mice, where almost all of the B cells start as ppc1-5H/ NAA B cells and the non-NAA B cells would have to be created by H chain editing. Indeed, all of the IgG hybridomas isolated from the immunized ppc1-5H/J del mice have undergone H editing, either by V H replacement at the targeted allele or by inactivation of the tg followed by rearrangement of the nontargeted allele. Three of the 19 IgG hybridomas showed evidence of V H replacement as assessed by the residual ppc1-5 VDJ junction sequence. Such a "footprint" however can be lost by nucleotide deletion and/or N addition associated with VDJ recombination. It is particularly true if the recipient VDJ junction is very short, such as that of the ppc1-5 V H . It has been reported that only ϳ20% of the V H replacement events would leave identifiable footprints (49) . Therefore, the frequency of V H replacement in ppc1-5 B cells is likely to be much higher. In support of this prediction is the increased usage of J H 3 among IgG hybridomas (12 of 19; Table I ) because J H 3 is part of the ppc1-5 VDJ H gene and would be left behind after the replacement of the ppc1-5 V H (Fig. 5B ).
Indeed, ongoing V H replacement at the ppc1-5H locus is readily detected in the bone marrow of ppc1-5 sd-tg mice. To our surprise, V H replacement signal ends and RAG gene expression were also identified in the spleen of the immunized ppc1-5 mice, especially in GL7 ϩ B cells. These findings, at face value, appear to suggest ongoing V H replacement in the GC B cells. However, such data have to be interpreted with caution since the identity of peripheral RAG-expressing B cells is controversial. In 1996 and 1997, several groups reported reexpression of RAGs and the presence of dsDNA breaks at the gene recombination signal ends in B220 low GL7 ϩ GC B cells (33, 50 -52) . Peripheral V H replacement has also been observed in mutating human tonsillar B cells (53) and synovial B cells of rheumatoid arthritis patients (54) . These have been taken to mean that secondary Ig gene rearrangement or receptor editing can be reinduced in mature GC or GC-like B cells upon Ag stimulation, a process termed "receptor revision" (55) . However, subsequent studies with RAG-GFP reporter mice have found that peripheral B cells expressing RAG had a phenotype of immature B cells (56 -58) . In addition, it has been shown that most of the RAG-expressing cells that accumulate in the spleen after immunization do not proliferate and that the accumulation of such cells is not Ag dependent since adjuvant alone can induce similar changes (59) . It is therefore concluded that the RAG-expressing B cells found in the spleen are newly emigrated immature bone marrow B cells rather than mature GC B cells. Another source of immature B cells in the spleen could be extramedullary hematopoiesis. Furthermore, SHM can result in dsDNA breaks in V H CDR3, which may be detected by LM-PCR. Taken together, our data indicate that the ppc1-5 B cells can undergo V H replacement and use it as a mechanism to alter the specificity and/or affinity of their BCR. However, it remains unclear at what developmental stage(s) V H replacement takes place in these B cells and whether such a process can be induced in the GC B cells upon Ag immunization. Additional experiments are required to clarify these issues.
Given that the ppc1-5H/1 NAA B cells are positively selected in primary development (27) and that they can participate in early anti-PC-KLH response and enter GCs, it is surprising that they are absent in the memory IgG response. One explanation could be that the ppc1-5H/1 NAAs are unable to improve their Ag binding sites via somatic mutation; alternatively somatic mutation of the ppc1-5 V H gene would result in reduced Ag binding or defective secretion (60, 61) . Either scenario would lead to the failure of ppc1-5/1 NAAs to compete with non-NAA B cells that do obtain better binding. The finding that some of the mutated non-ppc1-5 Abs had higher avidity for PC-KLH than the germline ppc1-5 Ab suggests that this may in part account for the disappearance of ppc1-5 NAA in memory response. However, we do not have direct evidence indicating that the ppc1-5 V H is particularly susceptible to deleterious mutations because we were not able to obtain hybridomas that express a mutated yet functional ppc1-5 V H . We are currently investigating this possibility by generating ppc1-5 V H mutants in vitro.
Several lines of evidence however suggest that affinity-based competition may not be the only reason for the absence of IgG ppc1-5/1 B cells in the memory response. First, most of the non-tg Abs derived from the memory response had lower affinity for PC-KLH than the ppc1-5 NAA. Second, as mentioned above, even in the absence of B cell competition, we were not able to retrieve IgG clones bearing ppc1-5H/1 BCR. The complete absence of ppc1-5/1 IgG clones of 509 hybridomas analyzed (300 from ppc1-5H mice and 209 from ppc1-5/Jk del mice) suggests powerful pressure to purge ppc1-5/1 NAA from the IgG Ab repertoire. Third, all memory IgG-Abs had lost anti-DNA activity, suggesting a selection against DNA binding. Comparison of the VDJ sequences of the V H ppc1-5 and V H 7183.20.37, the most frequently used non-tg V H by the IgG hybridomas reveals that although the two sequences share a high degree of homology, the ppc1-5 VDJ has three more arginine residues, one of which is in CDR3. It is known that arginines, particularly in V H CDR3, contribute significantly to DNA binding (62) . Indeed, none of the five V H 7183.20.37 Abs bound DNA and they only had modest avidity for PC-KLH (Table I) . Therefore, the repeated use of V H 7183.20.37 by the memory B cells may not be entirely due to selection for its high Ag-binding affinity; but rather selection against autoreactivity may play a role. These findings are consistent with a previous study in which dual specific B cells that bind the hapten p-azophenylarsonate and nuclear autoantigens were able to enter GCs, but they were absent in the memory compartment following p-azophenylarsonate immunization (63) . Forced expression of Bcl-2 could rescue these B cells, but the rescued B cells all had reduced autoreactivity as a result of somatic mutation. It was therefore postulated that negative selection against autoreactivity took precedence over positive selection for foreign Ag binding in multireactive B cells. Collectively, our results indicate that both the need for better Ag binding sites and the need for eliminating autoreactivity may be driving the counterselection of IgG ppc1-5 BCR.
In addition to GC regulation, other mechanisms may also control the differentiation of NAA B cells during an immune response. The finding that very few IgG ppc1-5H/1 B cells are present in both primary and memory responses points to a checkpoint linked FIGURE 6. Proposed developmental pathways of NAA and non-NAA B cells in ppc1-5H sd-tg mice during anti-PC-KLH-immune response. In the preimmune mature B cell repertoire, the NAA B cells (ppc1-5H/) constitute ϳ30% of the B cells and the remaining 70% are non-NAA B cells (ppc1-5H/ and non-tg). After the first immunization with PC-KLH, the NAA B cells quickly differentiate to EF AFCs and mount an early IgM response. Some of the non-NAA B cells that recognize PC-KLH also participate in the early Ab response. Both types of B cells can enter GCs, but they have different fates: the non-NAA B cells are able to differentiate to IgG memory B cells and post-GC AFCs, whereas the NAA B cells are arrested during their GC development, leading to the short-lived NAA Ab response. After the secondary immunization, the non-NAA memory B cells undergo extensive proliferation and produce large amounts of IgG Abs. In contrast, the NAA B cells do not proceed to memory response.
to CSR. This regulation could be independent of GC reaction because CSR can occur in the EF without somatic mutation (64) . Comparison of signal transduction between IgM and IgG BCRs has revealed that the latter has a distinct signal transduction profile that promotes plasma cells differentiation (65) (66) (67) . It would therefore not be surprising for the immune system to include a regulatory process at this "switch" point to prevent indiscriminate plasma cell differentiation and Ab production from self-reactive IgG B cells.
In summary, our data demonstrate that the ppc1-5 NAA-producing B cells are excluded from the IgG memory B cell compartment. The apparent "innocuous" natural autoimmunity is therefore not "ignored" by the tolerance mechanisms in nonautoimmune mice, but instead it is kept in check during an immune response to prevent the development of high-affinity anti-self-IgG Abs. Similar regulation of NAA has also been observed in humans. For example, natural autoreactive B cells expressing the V H 4-34 cold-agglutinin Ab are positively selected in the naive repertoire, but are excluded from the memory B cell compartment and from differentiation to plasma cells in healthy individuals (68) . However, in systemic lupus erythematosus patients, these B cells can develop to IgG plasma cells, indicating a defect in the control of NAA B cells as a cause of autoimmunity. Similarly, it has been reported that patients with systemic lupus erythematosus and rheumatoid arthritis have increased frequency of autoreactive/polyreactive B cells (69, 70) . It will be of great interest to determine whether the tolerance mechanism for ppc1-5 NAA is defective in autoimmune-prone animals and whether, in other circumstances, NAA can ameliorate autoimmunity.
